Buti M, Casado MA, Esteban R
Therapy a la carte is more cost-effective than standard combination therapy for naïve patients with chronic hepatitis C
57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Boston, Massachusetts, EEUU. 27-31 oct 2006
Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R
Cost-effectiveness of peginterferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-HCV co-infected patients
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) and awarded a Presidential Poster of Distinction. San Francisco, California, EEUU. 11-15 nov 2005
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). San Francisco, California, EEUU. 11-15 nov 2005
Buti M, Casado MA, Fosbrook L, Esteban R